William Fry recently advised Innocoll Holdings plc (NASDAQ: INNL) a global, commercial stage specialty pharmaceutical and medical device company, in respect of its corporate redomiciliation from Germany to Ireland. The move to Ireland also involved the termination of Innocoll’s existing ADR programme and the direct listing of shares on NASDAQ.

This redomiciliation was implemented by means of a cross-border merger under Irish and German law, the first time that a listed company has redomiciled to Ireland using this pan-European regime. The reorganisation will allow Innocoll to avail of a more favourable corporate legal regime in Ireland and reduce certain operational and other expenses.

The William Fry team advising on the deal included David Carthy, Laura Dunne, Sonya Manzor, David Fitzgibbon and David Jones.

William Fry’s mandate on the Innocoll redomiciliation maintains its position as a leader in advising on public company transactions including advising: King Digital Entertainment on its acquisition by Activision Blizzard Entertainment; IAG on its acquisition of Aer Lingus; the Department of Finance in assessing options regarding potential disposal of the State’s holdings in Allied Irish Banks plc (AIB) and Forest Laboratories in relation to its $28 billion merger with Actavis plc.

To speak to William Fry regarding Irish redomiciliation options please contact David Carthy or David Fitzgibbon.